Baxter International Inc. Stock Rises Tuesday, Still Underperforms Market

Universal Health Realty Income Trust

Change company Symbol lookup

Select an option...

UHT Universal Health Realty Income Trust

BBVA Banco Bilbao Vizcaya Argentaria SA

RILY B Riley Financial Inc

WTS Watts Water Technologies Inc

MMM 3M Co

ADTH AdTheorent Holding Company Inc

GAZ iPath? Series B Bloomberg Natural Gas Subindex Total ReturnSM ETN

SNAP Snap Inc

FNB FNB Corp

CNFR Conifer Holdings Inc

Real Estate : Equity Real Estate Investment Trusts (REITs) | Small Cap Blend

Company profile

Universal Health Realty Income Trust is a real estate investment trust. The Company invests in health care and human service related facilities, including acute care hospitals, behavioral health care hospitals, specialty facilities, free-standing emergency departments, childcare centers, and medical/office buildings. The Company’s portfolio consists of approximately 75 real estate investments or commitments located in approximately 21 states in the United States consisting of approximately six hospital facilities, including three acute care and three behavioral health care; approximately fifty-eight medical/office buildings; approximately four free-standing emergency departments; and approximately four preschool and childcare centers, and approximately three specialty facilities. The Company’s portfolio includes McAllen Medical Center, Wellington Regional Medical Center, Canyon Creek Behavioral Health and Clive Behavioral Health Hospital.

Baxter International Inc. Stock Rises Tuesday, Still Underperforms Market

4:39 pm ET October 25, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Baxter International Inc. (BAX) rallied 1.21% to $57.11 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.63% to 3,859.11 and the Dow Jones Industrial Average rising 1.07% to 31,836.74. Baxter International Inc. closed $32.59 below its 52-week high ($89.70), which the company achieved on February 9th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Thermo Fisher Scientific Inc. (TMO) rose 1.90% to $514.62, Medtronic PLC (MDT) rose 0.74% to $84.50, and Stryker Corp. (SYK) rose 1.87% to $224.62. Trading volume (4.7 M) eclipsed its 50-day average volume of 3.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled October 25, 2022.

(END) Dow Jones Newswires

October 25, 2022 16:39 ET (20:39 GMT)